thromboxane-a2 has been researched along with Hematologic-Diseases* in 2 studies
2 other study(ies) available for thromboxane-a2 and Hematologic-Diseases
Article | Year |
---|---|
UPLC-Q-TOF/MS-Based Plasma Metabolomics to Evaluate the Effects of Aspirin Eugenol Ester on Blood Stasis in Rats.
Aspirin eugenol ester (AEE) is a novel compound that is formed from the esterification of aspirin (acetylsalicylic acid (ASA)) and eugenol. This study aimed to investigate the effects of AEE on blood stasis in rats and to characterize the underlying mechanisms using a plasma metabolomic study. The results indicate that AEE and ASA could modulate whole blood viscosity (WBV), plasma viscosity (PV), blood coagulation parameters, platelet count, platelet aggregation, lactate dehydrogenase (LDH), creatinine (CR) and the levels of thromboxane A2 (TXA Topics: Animals; Aspirin; Blood; Blood Chemical Analysis; Blood Coagulation; Blood Viscosity; Chromatography, High Pressure Liquid; Disease Models, Animal; Epoprostenol; Eugenol; Female; Hematologic Diseases; Metabolomics; Platelet Aggregation; Rats; Thromboxane A2 | 2019 |
Hemorrhagic thrombocytopathy with platelet thromboxane A2 receptor abnormality: defective signal transduction with normal binding activity.
Subnormal platelet responses to thromboxane A2 (TXA2) were found in a patient with polycythemia vera, and the mechanism of this dysfunction was analyzed. The patient's platelets showed defective aggregation and release reaction to arachidonic acid, enzymatically generated TXA2 and synthetic TXA2 mimetics (STA2, U-46619). In contrast, they showed normal responses to thrombin. When the platelet TXA2 receptor was examined with both a 125I-labelled derivative of a TXA2 receptor antagonist ([125I]-PTA-OH) and a 3H-labelled TXA2 agonist ([3H]U-46619), the equilibrium dissociation rate constants (Kd) and the maximal concentrations of binding sites (Bmax) of the patient's platelets to both ligands were within normal ranges, suggesting that the binding capacity of their TXA2 receptor was normal. STA2 failed to induce normal elevation in the cytoplasmic free calcium ion concentration, phosphatidic acid formation and 40 kD protein phosphorylation in the patient's platelets, whereas these responses to thrombin were within normal ranges. 12-O-Tetradecanoyl-phorbol-13-acetate (TPA) also evoked normal response in the 40 kD protein phosphorylation in the patient's platelets. These results suggested that the patient's platelets had TXA2 receptor abnormalities which were characterized by defective transduction of the binding signal to postreceptor reactions after normal TXA2 binding. Topics: Adenine Nucleotides; Arachidonic Acid; Arachidonic Acids; Blood Platelets; Blood Proteins; Calcium; Cell Communication; Hematologic Diseases; Hemorrhage; Humans; Male; Middle Aged; Phosphatidic Acids; Phosphorylation; Platelet Aggregation; Receptors, Prostaglandin; Receptors, Thromboxane; Thromboxane A2 | 1987 |